Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?

✍ Scribed by Shelby Davies, Gabrielle Gold-von Simson

• Book ID: 120764081
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 132 KB
• Volume: 34
• Category: Article
• ISSN: 0172-0643
• DOI: 10.1007/s00246-013-0731-3